Navidea sells shares to raise funds for operations

01/30/2013 | Wall Street Journal, The

Navidea Biopharmaceuticals said it has sold 1.5 million shares to J.P. Morgan Chase & Co.'s asset management unit and an additional investor to raise money to support its operations while it waits for an FDA decision on its radiopharmaceutical agent Lymphoseek. Navidea expects a decision in April and is also pursuing European approval for the agent.

View Full Article in:

Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Director of Actuarial Services, Government Programs
PacificSource
Springfield, OR
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations